Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...
Saved in:
Main Authors: | M. Liontos, A. Andrikopoulou, K. Koutsoukos, C. Markellos, E. Skafida, O. Fiste, M. Kaparelou, N. Thomakos, D. Haidopoulos, A. Rodolakis, M. A. Dimopoulos, F. Zagouri |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b86ff7d8ecf44fa4ad5387a7df88a008 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fever during chemotherapy: Hypersensitivity reactions
by: Wen-Ling Lee, et al.
Published: (2021) -
Treatment of Cervical Pregnancy with Ultrasound-Guided Intragestational Injection of Methotrexate: A Case Report
by: Angeliki Rouvali, et al.
Published: (2021) -
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
by: Allan B. Huang, et al.
Published: (2021) -
A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
by: Mitchell Clark, et al.
Published: (2021) -
Correction to: Maternal and neonatal outcomes in mothers with diabetes mellitus in Qatari population
by: Mohammad A. A. Bayoumi, et al.
Published: (2021)